FindTrial
Sign In

Lovastatin for treating manic symptoms of bipolar disorder

Lovastatin effect on the symptom of bipolar mood disorder-manic phase

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201302203930N18
Enrollment
60
Registered
2013-04-06
Start date
2011-11-13
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolar mood disorder manic or mixed phase. Manic episode

Interventions

Intervention 1: Lovastatin 20 to 40 mg/day. Intervention 2: Placebo.
Treatment - Drugs
Placebo
Lovastatin 20 to 40 mg/day

Sponsors

Vice chancellor for research, Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Manic episode of bipolar mood disorder; both gender. Exclusion criteria: sever uncontrolled medical condition such as hypothyroidism; hypersensitivity to lovastatin; and pregnancy.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Young Mania Rating Scale. Timepoint: baseline, 2 week, and 4 week. Method of measurement: Interveiw.—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMotahhar Omrani Sigaroodi

Shiraz University of Medical sciences

motahhar_omrani@yahoo.com+98 71 1627 3070

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Mar 8, 2026